ABSTRACT Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. Mutations in this chloride channel lead to mucus accumulation, subsequent recurrent pulmonary infections, and inflammation, which, in turn, cause chronic lung disease and respiratory failure. Recently, rates of nontuberculous mycobacterial (NTM) infections in CF patients have been increasing. Of particular relevance is infection with Mycobacterium abscessus, which causes a serious, life-threatening disease and constitutes one of the most antibiotic-resistant NTM species. Interestingly, an increased prevalence of NTM infections is associated with worsening lung function in CF patients who are also coinfected with Aspergillus fumigatus. We established a new mouse model to investigate the relationship between A. fumigatus and M. abscessus pulmonary infections. In this model, animals exposed to A. fumigatus and coinfected with M. abscessus exhibited increased lung inflammation and decreased mycobacterial burden compared with those of mice infected with M. abscessus alone. This increased control of M. abscessus infection in coinfected mice was mucus independent but dependent on both transcription factors T-box 21 (Tbx21) and retinoic acid receptor (RAR)-related orphan receptor gamma t (ROR␥-t), master regulators of type 1 and type 17 immune responses, respectively. These results implicate a role for both type 1 and type 17 responses in M. abscessus control in A. fumigatus-coinfected lungs. Our results demonstrate that A. fumigatus, an organism found commonly in CF patients with NTM infection, can worsen pulmonary inflammation and impact M. abscessus control in a mouse model.
excavatum, and mitral valve prolapse (3) . The prevalence of chronic lung disease due to NTM is increasing and, in many areas of the United States, exceeds that of Mycobacterium tuberculosis.
The most common NTM causing pulmonary infection is the Mycobacterium avium complex, but other species, including Mycobacterium abscessus, are becoming more common in CF patients. M. abscessus infection accounts for up to 50% of NTM infections in some CF cohorts and is associated with decrease in lung function in CF patients (2) . In addition, it constitutes one of the most clinically virulent and antibioticresistant NTM species (4) . Treatment can be rendered difficult by the discordance that often occurs between in vitro antibiotic susceptibility tests and clinical effectiveness (1) . Treatment options are limited, with a treatment failure rate reported at ϳ50% for antibiotic treatment and lung resection sometimes being the only alternative (5) .
Mucus accumulation and inhibition of lung antimicrobial peptides due to high ion concentration are thought to underlie the increased predisposition of CF patients to infection. Numerous pathogens can persist in the lungs of CF patients and contribute to the decline in respiratory function (6) . Coinfections with NTM and other characteristic CF pathogens are common; Pseudomonas-derived genes have been identified in the genome of M. abscessus (7) . Furthermore, studies show that Pseudomonas aeruginosa and M. abscessus frequently coexist in the lung environment (8) . Similarly, Aspergillus fumigatus can colonize the lungs in CF patients and cause allergic bronchopulmonary aspergillosis (6) , and its presence is associated with increased risk of NTM infection (2) . It is not clear whether this association occurs because these CF patients have more severe lung disease or because of specific interactions between these pathogens.
In this context, common CF coinfections may alter the course of NTM disease, and the nature and mechanisms behind such relationships have not been studied in depth. A. fumigatus has been shown to induce type 17 cytokines (including the signature cytokine interleukin-17 ) and neutrophilia (9) , which has been associated with inflammation and impaired immune resistance in a mouse model (10) . Type 17 responses are beneficial for A. fumigatus persistence, given that they inhibit the type 1 responses required to control infection and promote biofilm formation (9, 11) . Given the importance of type 1 immunity in mycobacterial control, a preexisting A. fumigatus infection could affect mycobacterial containment and impact disease pathology. In addition, neutrophils have been shown to promote M. abscessus biofilm formation, thereby promoting bacterial persistence (12) . A. fumigatus has also evolved other strategies to evade the immune response, among which is Toll-like receptor 2-dependent stimulation of IL-10 secretion (13) . Previous work has demonstrated that peripheral blood mononuclear cells (PBMC) from CF patients, in comparison to PBMC from healthy controls, secreted increased IL-10 levels when exposed to A. fumigatus antigens (13) . Upon blockade of IL-10, type 1 responses were enhanced, suggesting that IL-10 may play a role in inhibiting A. fumigatus T cell responses in CF (14) . This raises the question of whether such inhibition of the immune response by A. fumigatus may affect concomitant immunity to NTM infections and their associated pathology.
In this work, we used a mouse model to study the effect of prior infection with A. fumigatus infection on challenge with M. abscessus. In this model, animals exposed to A. fumigatus and coinfected with M. abscessus exhibited increased lung inflammation and decreased mycobacterial burden compared to those of mice infected with M. abscessus alone. The increased control of M. abscessus infection was mucus independent but dependent on the presence of both transcription factors T-box 21 (Tbx21) and retinoic acid receptor (RAR)-related orphan receptor gamma (ROR␥-t). As these transcription factors are the master regulators of type 1 and type 17 immune responses, respectively, this suggests a role for type 1 and type 17 responses in M. abscessus control in coinfected hosts. Together, our data provide novel insights into how A. fumigatus, an organism frequently found in CF patients, affects the pathology and control of the opportunistic NTM pathogen M. abscessus.
RESULTS
Prior A. fumigatus infection worsened lung pathology and improved M. abscessus control in an acute model of coinfection. A. fumigatus commonly colonizes the lungs in CF patients (6) and is associated with an increased frequency of NTM infection (2) . The contribution of A. fumigatus infection to M. abscessus disease, however, has not been studied. We therefore addressed the effect of A. fumigatus coinfection on M. abscessus control and associated lung pathology using a mouse model. We hypothesized that the A. fumigatus-induced immune response may alter M. abscessusdriven pathology and control. Given that the IL-17 response is critical in promoting A. fumigatus-driven inflammation and host susceptibility (10), we initially determined the kinetics of IL-17 induction in the lungs of A. fumigatus-infected mice. When C57BL/6 (B6) mice were infected with A. fumigatus, lung IL-17-producing lymphocytes accumulated by day 4; the majority of the IL-17-producing cells were found to be CD4 ϩ T cells and ␥␦ T cells (Fig. 1A to C) . The accumulation of IL-17-producing cells in the infected lung also coincided with induction of Il17 mRNA between day 1 and 4 postinfection (Fig. 1D ). These data suggest that Il17 is induced by day 4 after A. fumigatus infection.
Therefore, in subsequent experiments, mice were infected with A. fumigatus, followed by initial challenge with M. abscessus 3 days later, to coincide with the peak of the A. fumigatus-induced IL-17 response. Following M. abscessus infection, at 14 days, coinfected mice exhibited improved M. abscessus control ( Fig. 2A) PAS stain of FFPE lung sections to assess mucus and glycogen was performed and assessed at a magnification of ϫ200. (E to G) The numbers of neutrophils (CD11b ϩ GR1 ϩ ) (E), alveolar macrophages (CD11c ϩ ; high autofluorescence) (F), and MHC class II-positive alveolar macrophages (MHC-II ϩ CD11c ϩ ; high autofluorescence) (G) were determined in lungs of coinfected mice 14 dpi using flow cytometry. n ϭ 5 for all groups. *, P Յ 0.05; **, P Յ 0.01; ****, P Յ 0.0001.
( Fig. 2B and C). These foci were composed predominantly of eosinophils and histiocytes and were associated with increased mucus accumulation as evidenced by periodic acid-Schiff (PAS) staining (Fig. 2D ). Flow cytometry showed the presence of significantly more neutrophils, alveolar macrophages, and major histocompatibility complex (MHC) class II-activated alveolar macrophages in the coinfected mice compared to responses in the lungs of mice infected with M. abscessus alone (Fig. 2E to G). The accumulation of lung neutrophils and alveolar macrophages in mice infected with A. fumigatus alone was not significantly different from that in coinfected mice, suggesting that the increased accumulation of inflammatory myeloid cells was likely driven by A. fumigatus infection.
A. fumigatus-induced M. abscessus control in coinfected mice is Stat6 independent. As A. fumigatus infection caused mucus accumulation in airways, we next studied whether increased mucus may impair M. abscessus attachment to lung epithelial cells, thus decreasing bacterial burden in coinfected mice. We challenged A. fumigatusinfected mice with M. abscessus and assessed lung bacterial burden 1 h following infection. However, M. abscessus burden did not significantly differ between control and A. fumigatus-infected mice, suggesting that the effects of A. fumigatus on M. abscessus control occur at a later point during infection (Fig. 3A) . We further tested the importance of mucus production on A. fumigatus-induced M. abscessus control by infecting Stat6 Ϫ/Ϫ mice, which are unable to produce mucus in response to antigen challenge (15) . Coinfected Stat6 Ϫ/Ϫ mice were able to control M. abscessus to an extent similar to that for C57BL/6 mice (Fig. 3B) , indicating that mucus production does not directly impact M. abscessus control.
A. fumigatus enhances control of M. abscessus through a Tbx21 and Rorcdependent mechanism. As A. fumigatus infection induced lung IL-17-producing cells following infection (Fig. 1) , we then studied the accumulation of IL-17-and gamma interferon (IFN-␥)-producing cells upon coinfection with M. abscessus. We found that coinfected mice showed enhanced accumulation of IL-17-producing and IL-17/IFN-␥-coproducing CD4 ϩ CD44 ϩ T cells (Fig. 4A and B) . Similarly, coinfected mice had increased numbers of IL-17-producing ␥␦ T cells (Fig. 4C ). There was a trend toward increased IL-17/IFN-␥-coproducing ␥␦ T cells, but this was not statistically increased in coinfected mice compared with the singly infected mice (Fig. 4D) . CD4 ϩ CD44 ϩ T cells producing IFN-␥ alone mirrored more closely the responses observed in M. abscessus- abscessus-specific T cells were determined in the lungs of infected mice 14 dpi using an antigen-driven ELISpot assay. n ϭ 3 to 5 for all groups. *, P Յ 0.05; **, P Յ 0.01; ***, P Յ 0.001. infected mice (Fig. 4E) . Furthermore, while coinfected mice harbored higher numbers of M. abscessus-specific IL-17-producing cells in their lungs, there was no significant increase in accumulation of M. abscessus-specific IFN-␥-producing cells (Fig. 4F and data  not shown) . Thus, our data show that T cells producing IL-17 and IFN-␥ accumulate in the lungs of coinfected mice. We then further determined the immune mechanisms responsible for improved M. abscessus control in coinfected mice. First, we infected Il-17ra Ϫ/Ϫ mice with M. abscessus alone or coinfected mice with A. fumigatus and M. abscessus. While the lung bacterial burden in Il-17ra Ϫ/Ϫ mice infected with M. abscessus alone did not differ from that in M. abscessus-infected B6 mice, we found that Il-17ra Ϫ/Ϫ coinfected mice had a higher lung bacterial burden than coinfected B6 mice (Fig. 5A) . This indicates that IL-17RA signaling is partially involved in A. fumigatus-induced M. abscessus control. Because interferon signaling has been established to be important for anti-NTM responses and control (16), we next determined the effect of STAT1 deficiency on A. fumigatus-induced M. abscessus control. Stat1 Ϫ/Ϫ mice demonstrated increased bacterial burden upon M. abscessus single infection, and decreased control of M. abscessus in coinfected mice, compared to that of B6 mice (Fig. 4A) . These results indicate that interferon signaling via the STAT1 pathway is required for the protection observed in coinfected mice. As multiple mechanisms may simultaneously contribute to M. abscessus control in coinfected mice, we next coinfected Tbx21 Ϫ/Ϫ , Rorc Ϫ/Ϫ , or Tbx21 Ϫ/Ϫ Rorc Ϫ/Ϫ mice, which lack type 1, type 17, or both type 1 and type 17 responses, respectively. We found that individually, each transcription factor was dispensable for A. fumigatus-induced M. abscessus protection at 14 days (Fig. 5B) . However, coinfected mice lacking both transcription factors failed to improve protection against M. abscessus challenge (Fig. 5B) . On histologic analysis, Rorc Ϫ/Ϫ mice and Tbx21 Ϫ/Ϫ Rorc Ϫ/Ϫ mice exhibited higher numbers of inflammatory foci than did B6 coinfected mice and Tbx21 Ϫ/Ϫ coinfected mice (Fig. 5C ), as well increased lung pathology ( Fig. 5D and E) . Together, these results suggest a role for both type 1 and type 17 responses in control of M. abscessus in A. fumigatus-coinfected mice.
Prior A. fumigatus infection worsened lung pathology and improved M. abscessus control in a chronic model of coinfection. Our data show that A. fumigatus infection worsens lung pathology upon subsequent M. abscessus infection in an acute (14 day) model of coinfection. Thus, we extended the duration of infection to determine whether similar findings could be obtained in a chronic coinfection model which would better mimic infection in CF patients.
When B6 mice were coinfected with A. fumigatus and M. abscessus, at 30 days no bacterial burden could be detected (data not shown). To create a chronic model of infection, B6 mice were initially infected with A. fumigatus and then over the next 30 days were serially infected 4 times with M. abscessus. A control group of B6 mice were also serially infected 4 times with M. abscessus alone over the 30 days. Similar to the results of the 14-day experiment described above, chronically coinfected mice exhibited improved clearance of M. abscessus (Fig. 6A) , as well as increased inflammation (Fig.  6B to D) as exhibited by increased numbers of inflammatory foci. These results thus demonstrate that prior A. fumigatus infection can worsen lung pathology even in a chronic model of M. abscessus coinfection.
Fungal antigens improve in vitro killing of M. abscessus. A potential mechanism leading to improved control of M. abscessus and increased pathology in A. fumigatusinfected mice could be through activation of macrophages to induce M. abscessus killing. To further investigate this, bone marrow-derived macrophages (BMDMs) were generated and treated with fungal products, including zymosan and curdlan, following which they were infected with M. abscessus. Interestingly, similar to the case for IFN-␥-treated macrophages, both zymosan and curdlan treatment improved M. abscessus control in macrophages (Fig. 7A) , and this was associated with increased activation of macrophages, as measured by inducible nitric oxide synthase (iNOS) accumulation in supernatants (Fig. 7B) . These studies indicate that fungal antigens may potentiate Representative lung pathology is shown from B6 control mice and A. fumigatus-coinfected B6 mice (D) and A. fumigatus-coinfected Tbx21 Ϫ/Ϫ mice, Rorc Ϫ/Ϫ mice, and Tbx21 Ϫ/Ϫ Rorc Ϫ/Ϫ mice (E). n ϭ 3 to 5 for all groups. *, P Յ 0.05; **, P Յ 0.01; ***, P Յ 0.001. macrophage activation, which could, in turn, improve M. abscessus control in coinfected mice while also worsening lung pathology.
DISCUSSION
One of the hallmarks of CF is the presence of recurrent pulmonary exacerbations due to infections, which are associated with a decline in lung function (17, 18) . CF patients often harbor a variety of pathogens in their lungs, and how such infections interact with each other to affect lung function is still unknown. Several recent studies showed that A. fumigatus colonization is frequently associated with M. abscessus infection (2, 19, 20) . This association may be due to more advanced disease that predisposes patients to M. abscessus infection, but also to host-pathogen interactions. M. abscessus-infected CF patients are more likely to have previously received intravenous (i.v.) antibiotics for other infections and to have A. fumigatus isolated from their sputa (19) . Thus, frequent antibiotic treatment for bacterial infections could lead to the generation of an ecologic niche that enables survival of both A. fumigatus and M. abscessus in CF patients. However, one infection also may directly affect the other through host-intrinsic mechanisms, such as modulation of immune responses.
Using a mouse model of coinfection between A. fumigatus and M. abscessus, we sought to determine the effect of A. fumigatus on lung pathology and protection in M. abscessus infection. Upon infection with M. abscessus, previous A. fumigatus infection worsened lung pathology and improved immune control of M. abscessus. Using several gene-deficient mouse strains, we showed that the improved control was partly IL-17RA and STAT1 signaling dependent. In addition, when both T-bet and ROR␥-t, the master transcription factors for the type 1 and type 17 responses, respectively, were absent, A. fumigatus-induced protection was lost. These data suggest that the type 1 and type 17 pathways, or innate immune cells expressing T-bet and ROR␥-t, can act together to control M. abscessus infection in coinfected mice. This is in accordance with previous findings in M. tuberculosis infection, where IL-23 was shown to compensate for IL-12p70 deficiency and to stimulate the induction of M. tuberculosis-specific type 1 and type 17 cells (21) . In addition, innate immune cell activation may contribute to enhanced M. abscessus control in coinfected mice, as in vitro stimulation of macrophages with the fungal ␤-glucan products zymosan and curdlan promoted enhanced macrophage activation and M. abscessus killing. ␤-Glucans can signal through a variety of immune receptors, including complement receptor 3 (CR3), Toll-like receptors 2 and 6, and dectin 1, which is thought to be the main ␤-glucan receptor on leukocytes (22) . Previous studies have found that macrophages can become activated in response to ␤-glucans, increasing tumor necrosis factor alpha and inducible nitric oxide synthase (iNOS) expression in a myeloid differentiation primary response gene 88 (MyD88)-and nuclear factor kappa B (NF-B)-dependent manner (23) (24) (25) . Thus, both innate and adaptive immunity may contribute to M. abscessus containment in coinfected mice.
Our mouse model provides novel insights into human findings showing that coinfection of NTM and A. fumigatus is associated with lung function decline in CF (2). We observed enhanced immune control of M. abscessus in mice coinfected with A. fumigatus; however this came at the expense of increased lung pathology. In patients with cystic fibrosis, mucus accumulation and ineffectiveness of lung antimicrobial peptides prevent infections from being readily cleared (6) . Thus, A. fumigatus and M. abscessus coinfection in a CF patient who is unable to easily clear infection could lead to a cycle of inflammation and lung damage, contributing to a decline in pulmonary function observed in studies (2) . Even with antimicrobial treatment and eventual clearance of NTM, it is conceivable that CF patients coinfected with A. fumigatus and M. abscessus could experience a decline in lung function due to prolonged lung damage during a year-long treatment course. PBMC from CF patients secreted increased amounts of IL-10 compared to healthy controls when exposed to recombinant A. fumigatus antigens (14) . Blockade of IL-10 resulted in enhanced type 1 responses, The number of viable bacteria within BMDMs was determined by plating (A) and nitrite levels in the supernatants were determined using Griess assays (B). *, P Յ 0.05; **, P Յ 0.01; ***, P Յ 0.001; ****, P Յ 0.0001.
suggesting a role for IL-10 in inhibiting A. fumigatus T cell responses in CF (14) . This could represent an adaptive mechanism in CF patients in response to a prolonged cycle of lung inflammation and damage due to chronic infection with A. fumigatus and other organisms. In the current study, we have established an acute and chronic model of A. fumigatus and M. abscessus coinfection in wild-type B6 mice. Although coinfection in B6 mice does not recapitulate all the features of human chronic lung inflammation seen in CF patients, the in vivo model described here provides a new platform to understand the host immune parameters for pathogens such as A. fumigatus and M. abscessus, which often coexist in CF patients (2) . Future studies could refine the establishment of a chronic coinfection model which will enable the delineation of the immune factors that limit pathogenesis and/or drive chronic coinfection seen in human CF patients.
In summary, our results demonstrate that A. fumigatus, a CF-prevalent fungal organism, can worsen pulmonary pathology and inflammation and improve M. abscessus control early during M. abscessus infection. This improved control was partly IL-17RA and STAT1 signaling dependent and was dependent on both T-bet and ROR␥-t. These findings also provide novel insight into the immune mechanisms regulating clearance of M. abscessus in a mouse model. The long-term effects of A. fumigatus coinfection on M. abscessus control and pathology, as well as the clinical significance of these findings, may be elucidated in future studies. Future work should include studying the effects of A. fumigatus and M. abscessus coinfection in an immunocompromised or CF animal model, which would allow for impaired clearance of pathogens and chronic prolonged infection. It would be important to determine whether prolonged coinfection would result in deterioration in lung function, as has been observed in some human cohorts. Previous work has demonstrated that chronic A. fumigatus infection is a risk factor for pulmonary exacerbations in CF patients (26) . Currently, the indications for treatment of A. fumigatus colonization in CF patients are unclear and based on limited data. Thus, it would be useful to determine whether treatment of A. fumigatus may impact the course of M. abscessus infection and prevent deterioration of lung function. Finally, the precise downstream effects of the master transcription factors T-bet and ROR␥-t, which regulate M. abscessus clearance in our model, should be further clarified.
MATERIALS AND METHODS
Animals. C57BL/6 (B6) animals were purchased from Taconic. Ifn␥ Ϫ/Ϫ (27) mice on the B6 background were purchased from The Jackson Laboratory (Bar Harbor, ME). Il17ra Ϫ/Ϫ (28), Stat6 Ϫ/Ϫ (29), Tbx21 Ϫ/Ϫ (30), Rorc Ϫ/Ϫ (31), and Tbx21 Ϫ/Ϫ Rorc Ϫ/Ϫ mice, all on the B6 background, were bred and maintained in the animal facility at the University of Pittsburgh and Washington University in St. Louis, MO. Stat1 Ϫ/Ϫ mice were a kind gift from John Alcorn (University of Pittsburgh). Experimental mice were age and sex matched and used between the ages of 6 and 8 weeks. All mice were used following the National Institutes of Health guidelines for housing and care of laboratory animals and in accordance with University of Pittsburgh and Washington University in St. Louis Institutional Animal Care and Use Committee guidelines. All efforts were made to minimize suffering and pain as described in these approved protocols.
Experimental infections. M. abscessus strain L948 (ATCC 19977) was grown in Middlebrook 7H9 broth containing 0.05% Tween 80 to mid-log phase and frozen in 1-ml aliquots at Ϫ80°C. For M. abscessus infections, animals underwent oropharyngeal infection with 2 ϫ 10 4 CFU of bacteria using the tongue-pull method (32) . Briefly, mice were anesthetized with 3% isoflurane and suspended by their front incisors, and the tongue was extended using forceps. The bacterial suspension was pipetted into the trachea, and the tongue was held until normal breathing resumed. For 14-day experiments, mice underwent infection with M. abscessus on day 0. For 30-day experiments, mice underwent repeat infections with M. abscessus on days 0, 7, 14, and 21. Lung bacterial burden was established by plating out organ homogenates on 7H10 agar plates. A. fumigatus Fresenius (ATCC 42202) was grown on potato agar dextrose medium. For coinfection with A. fumigatus, mice underwent a single oropharyngeal infection with 2.5 ϫ 10 7 A. fumigatus conidia 3 days prior to the first M. abscessus challenge as described above.
Lung single-cell preparation and detection of cytokine-producing cells by ELISpot assay. Lung suspensions from M. abscessus-infected mice were prepared as described previously (33) and were used in enzyme-linked immunosorbent spot (ELISpot) assays as described below. Antigen-specific gamma interferon (IFN-␥)-producing and IL-17-producing cells were analyzed by ELISpot assay. MultiScreen-HA filter plates (Millipore, Billerica, MA) were coated with antibodies to IL-17 (R&D Systems, Minneapolis, MN). Single-cell suspensions were added to the plate at a starting concentration of 1 ϫ 10 5 cells/well and doubling dilutions were made. Cells were cultured overnight in the presence of 1 ϫ 10 6 irradiated splenocytes, 10 g/ml of heat-killed M. abscessus, and 10 U/ml of recombinant mouse IL-2 (eBioscience,
